Compare SLS & DRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLS | DRD |
|---|---|---|
| Founded | 2012 | 1895 |
| Country | United States | South Africa |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 2007 | 2002 |
| Metric | SLS | DRD |
|---|---|---|
| Price | $11.50 | $24.02 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $32.50 | N/A |
| AVG Volume (30 Days) | ★ 5.0M | 197.2K |
| Earning Date | 11-11-2026 | 10-23-2026 |
| Dividend Yield | N/A | ★ 4.19% |
| EPS Growth | ★ 50.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.33 |
| Revenue Next Year | N/A | $18.47 |
| P/E Ratio | ★ N/A | $15.32 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.39 | $19.47 |
| 52 Week High | $15.88 | $39.37 |
| Indicator | SLS | DRD |
|---|---|---|
| Relative Strength Index (RSI) | 48.42 | 42.91 |
| Support Level | $10.78 | $23.19 |
| Resistance Level | $12.62 | $26.30 |
| Average True Range (ATR) | 0.85 | 0.65 |
| MACD | 0.05 | 0.07 |
| Stochastic Oscillator | 58.58 | 27.89 |
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment, including exploration, extraction, processing, and smelting. Its reportable operating segments are: Ergo and FWGR. Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and FWGR is a surface gold retreatment operation that treats old slime dams in the West Rand goldfields. The Ergo segment derives the vast majority of the company's revenue.